 |
|
Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study
Young Sup Woo, Joo Eon Park, Do-Hoon Kim, Inki Sohn, Tae-Yeon Hwang, Young-Min Park, Duk-In Jon, Jong-Hyun Jeong, Won-Myong Bahk
Psychiatry Investig. 2016;13(4):458-467. Published online 2016 Jul 25 DOI: https://doi.org/10.4306/pi.2016.13.4.458
|
|
Comparative Efficacy, Safety and Tolerability of Olanzapine and Blonanserin in Patients with Schizophrenia: A Parallel Group Study
S. Chattopadhyay, U. Roy, S. Biswas, P. Roy, P. Mandal
Acta Medica Bulgarica.2021; 48(2): 45. CrossRef Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
Young Sup Woo, Bo-Hyun Yoon, Bong-Hee Jeon, Jeong Seok Seo, Beomwoo Nam, Sang-Yeol Lee, Young-Myo Jae, Sae-Heon Jang, Hun Jeong Eun, Seung-Hee Won, Kwanghun Lee, Jonghun Lee, Won-Myong Bahk
Clinical Psychopharmacology and Neuroscience.2019; 17(3): 423. CrossRef
|